These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7703186)

  • 1. Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies.
    Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Biomater Sci Polym Ed; 1994; 6(8):695-705. PubMed ID: 7703186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of human anti-factor VIII antibodies for functional polystyrene supports.
    Dahri L; Stoltz JF; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Mol Recognit; 1996; 9(5-6):401-6. PubMed ID: 9174917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic sorbents for removal of factor VIII inhibitors from haemophilic A plasma.
    Dahri L; Boisson-Vidal C; Regnault V; Muller D; Sultan Y; Stolz JF
    J Chromatogr B Biomed Appl; 1995 Feb; 664(1):47-54. PubMed ID: 7757240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorption of immunoglobulin G and anti-factor VIII inhibitory antibody from haemophiliac plasma to derivatized polystyrenes.
    Cornelius RM; Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J; Brash JL
    Biomaterials; 1997 Mar; 18(5):429-36. PubMed ID: 9061184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
    Huguet HC; Lasne D; Rothschild C; Siali R; Jozefonvicz J
    Thromb Haemost; 2004 Feb; 91(2):259-66. PubMed ID: 14961152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patients.
    Boisson-Vidal C; Haouam M; Lakhiari H; Huguet H; Dahri L; Sultan Y; Jozefonvicz J; Siali R
    Vox Sang; 2002 Oct; 83(3):214-21. PubMed ID: 12366762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic antibodies to factor VIII in haemophilia A.
    Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S31-4. PubMed ID: 14567533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG.
    Moreau A; Lacroix-Desmazes S; Stieltjes N; Saenko E; Kaveri SV; D'Oiron R; Sultan Y; Scandella D; Kazatchkine MD
    Blood; 2000 Jun; 95(11):3435-41. PubMed ID: 10828026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.
    Villard S; Lacroix-Desmazes S; Kieber-Emmons T; Piquer D; Grailly S; Benhida A; Kaveri SV; Saint-Remy JM; Granier C
    Blood; 2003 Aug; 102(3):949-52. PubMed ID: 12676786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors.
    Grosbois SS; Brionne MF; de Longcamp AL; Gautier P; V Kaveri S; Borel-Derlon A; Repessé Y
    Haemophilia; 2013 Mar; 19(2):322-9. PubMed ID: 23216758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Kazatchkine MD; Kaveri SV
    Haematologica; 2000 Oct; 85(10 Suppl):89-92. PubMed ID: 11187883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
    Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
    Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.